• TBXA2R-ERM Axis Drives Metastatic Behavior in TNBC Cells

  2026-05-20

  This article discusses a pivotal study revealing how the thromboxane A2 receptor (TBXA2R) activates the ERM protein family to enhance motility, invasion, and metastatic colonization of triple-negative breast cancer (TNBC) cells. The findings clarify a GPCR-driven signaling pathway underlying metastatic spread, with broad implications for designing anti-metastatic interventions and cannabinoid receptor research.

• ML216, BLM Helicase Inhibitor: Mechanism, Benchmarks & Appli

  2026-05-19

  ML216 is a potent, selective small molecule BLM helicase inhibitor with submicromolar activity. It enables precision DNA repair studies and supports synthetic lethality research in cancer models. This dossier details its biochemical, cellular, and translational benchmarks.

• Tetrahydromagnolol: Enhancing CB2 Assays & Workflow Reliabil

  2026-05-19

  This article guides lab teams in optimizing cell viability and cannabinoid signaling studies with Tetrahydromagnolol (SKU C5552), a highly selective peripheral CB2 receptor agonist. Drawing on real-world scenarios, it highlights data-driven best practices, supplier comparison, and protocol refinements that underpin reproducible, sensitive results for biomedical researchers.

• AT-406 (SM-406): Applied Workflows for Apoptosis Research

  2026-05-18

  AT-406 (SM-406) empowers cancer researchers to dissect and modulate apoptosis pathways with reproducibility and translational relevance. This guide details robust experimental workflows, protocol optimizations, and troubleshooting insights that leverage AT-406’s unique IAP inhibition profile for advanced oncology models.

• ER Stress and Reprogramming Drive Pro-Metastatic Tumor State

  2026-05-18

  Conod et al. (2022) reveal that tumor cells surviving imminent cell death can acquire stable, prometastatic states via ER stress and cellular reprogramming, orchestrating a cytokine storm that recruits additional migratory cells. This mechanistic insight reframes the origins of metastasis and highlights new intervention points for cancer therapy.

• AT-406 (SM-406): Structural Precision for IAP-Targeted Apopt

  2026-05-17

  Explore how AT-406 (SM-406) enables rigorous, structure-guided modulation of apoptosis in cancer cells. This article uniquely dissects the intersection of atomic-level death domain assembly and practical assay optimization, advancing AT-406's role in translational oncology.

• Neurotensin in GPCR Trafficking: Protocols and Troubleshooti

  2026-05-16

  Neurotensin empowers researchers to dissect GPCR trafficking and miRNA regulation in gastrointestinal models with exceptional purity and reproducibility. APExBIO’s validated reagent overcomes spectral interference, streamlining workflows for advanced mechanistic studies and robust data interpretation.

• T-5224 for Neuroimmune Modulation: Beyond Arthritis Models

  2026-05-15

  Explore the multifaceted potential of T-5224, a C-Fos/AP-1 inhibitor, in neuroinflammation and pain research. This in-depth review uncovers novel mechanistic insights and practical assay approaches, offering researchers a unique toolbox for inflammation modulation.

• Super-Enhancer Hijacking of LINC01977 Drives Early LUAD via

  2026-05-15

  Zhang et al. reveal that super-enhancer (SE) hijacking of the lncRNA LINC01977 promotes early-stage lung adenocarcinoma (LUAD) malignancy by intensifying canonical TGF-β/SMAD3 pathway activation. Their integrative approach uncovers a reciprocal regulatory loop among LINC01977, SMAD3, and tumor-associated macrophages, highlighting a potential epigenetic therapeutic target and advancing mechanistic understanding of LUAD progression.

• Auranofin as a Metabolic Disruptor: Redox and Apoptosis Insi

  2026-05-14

  Discover how Auranofin, a leading thioredoxin reductase inhibitor, uniquely disrupts cancer cell metabolism and redox homeostasis. This in-depth analysis connects mechanistic evidence with advanced protocol guidance for metabolic and apoptosis research.

• SB 431542: ALK5 Inhibitor Workflows for TGF-β Pathway Resear

  2026-05-14

  SB 431542 offers reproducible, selective inhibition of the TGF-β pathway, streamlining cell-based assays in fibrosis, cancer, and immunology. This guide translates bench evidence and recent breakthroughs into actionable protocols, troubleshooting, and advanced applications using APExBIO’s trusted ALK5 inhibitor.

• Clozapine: Experimental Workflows in Schizophrenia Research

  2026-05-13

  Unlock the power of Clozapine for dissecting antipsychotic mechanisms and modeling neurotoxicity in preclinical schizophrenia research. This guide delivers protocol enhancements, troubleshooting insights, and context from landmark studies—empowering your lab to achieve reproducible, high-impact results.

• YAP-TEAD and Super-Enhancer Networks in Surface Ectoderm Fat

  2026-05-13

  This study by Wang et al. reveals that YAP-TEAD transcriptional activity orchestrates the formation of super-enhancers crucial for early surface ectoderm commitment. By mapping the enhancer landscape and perturbing regulatory nodes, the authors establish a causal link between super-enhancer networks and cell fate, providing new insight into lineage regulation and regenerative potential.

• BAPTA Calcium Chelator: Precision Control in Cell Signaling

  2026-05-12

  BAPTA unlocks high-resolution modulation of intracellular calcium, enabling researchers to dissect complex apoptosis and cell signaling mechanisms, even under environmental toxin co-exposures. This guide details optimized workflows, critical protocol parameters, and actionable troubleshooting to maximize reproducibility and mechanistic insight using APExBIO's high-purity BAPTA.

• Dual-Genome OXPHOS Disruption: LRPPRC Inhibition and Dasatin

  2026-05-12

  This study reveals that combining LRPPRC inhibition with dasatinib induces a potent, synergistic anti-tumor effect by coordinately disrupting both mitochondrial and nuclear-encoded OXPHOS gene expression. The work establishes a mechanistic rationale for dual-genome metabolic targeting in cancer therapy and provides a foundation for future translational strategies.

15152 records 1/1011 page Next 12345 下5页 Last page